Introduction
Recently, we reported on the in vitro [1] and in vivo [2] animal safety (rat) of four-drug nerve block (multimodal perineural anesthesia-analgesia, or MMPNA) combinations involving bupivacaine (BPV [2] ), ropivacaine (RPV [1] ), or midazolam (MDZ [1, 2] ) with the following three preservative-free injectable drugs: clonidine, buprenorphine, and dexamethasone [1, 2] (hereafter abbreviated as CBD). In addition, we provided clinical benchmark data for patients having received nerve blocks with combined BPV-CBD [3] and MDZ-CBD [4] ). The chronological time frame for these previous clinical benchmark reports [3, 4] was July 2011 through March 2014. The current report covers intermediate and long-term peripheral nerve injury (PNI) outcomes for n ¼ 1830 patient-block encounters dating from July 2011 through December 2014.
We define a "patient-block encounter" as a uniquely identified patient encounter receiving one or more nerve blocks on a specific day for pre-and intra-operative anesthesia/analgesia, immediate postoperative analgesia, or rescue postoperative analgesia on a day after surgery, typically during the same hospital stay. The blocks used for these 1830 patient-block encounters were composed primarily of BPV-CBD (n ¼ 1726; 94.3%), or MDZ-CBD (n ¼ 104; 5.7%). Patients who were having surgery related to a current or previous surgical site infection typically did not have blocks that included perineural dexamethasone (n ¼ 109/1830, or 6%).
The objective of this report is to present complicationrelated quality improvement (QI) data from our institution in the epidemiologic context of such data published elsewhere regarding the risk of PNI complications related to surgery itself (without specific nerve block considerations) or specifically related to nerve blocks typically using local anesthetics only (in the absence of multiple or any perineural adjuvants).
In our institution (Veterans Affairs Pittsburgh Healthcare System, VAPHS), the lead author was charged with creating a regional anesthesia (RA) and analgesia program for patients eligible for peripheral nerve blocks. The VAPHS Medical Executive Board approved the lead author's recommendation to routinely use the described four-drug nerve blocks off-label. These single-injection nerve blocks are typically placed before surgery to provide postoperative analgesia and intraoperative anesthesia when feasible. Pursuant from institutional approval was the need to collect QI data prospectively (within 2 weeks after the block encounter) to evaluate dose-specific comparative effectiveness (block duration and rebound pain, which we previously reported [5, 6] ). Additional QI data were later collected retrospectively to determine perineural complications and to establish MMPNA safety. In accordance with Veterans Health Administration Handbook 1058.05, this manuscript was processed for authentication of nonresearch status of the described activities prior to submission to this journal. The VAPHS institutional review board declared these clinical operations "not research" at the time of program initiation (mid-2011) and annually since then during required reviews.
Methods
Definition of perineural complication. This medical record review identified patients who had EMG examinations after the date of the described patient-block encounter. Included was a review of the EMG consultation order, and the specific progress notes time-associated with the EMG order. The review also entailed the screening of postoperative notes by the surgical team following up on the patient for any notes indicating potential PNI symptoms that were traceable to the site of the needle injection for the performed blocks, but for which EMG was not ordered. This medical record review did not track complications (e.g., intraoperative hypotension, postoperative nausea/vomiting) other than neurologic symptoms in the distribution of the surgery and/or nerve block(s).
Patient selection for data analysis of QI-reportable occurrences, and data collation. From July 1, 2011 through December 31, 2014, there were n ¼ 1830 patient-block encounters involving MMPNA in an all-inclusive QI database. For QI purposes, electronic medical records with patient identifiers for cases 1 through 800 were screened by author AJG, including postoperative notes by the surgical team and/or any other relevant progress notes (e.g., neurology, physical medicine and rehabilitation) that may have indicated possible PNI outcomes. In addition, all electronic medical records were screened for any EMG testing procedures that were done before or after the index MMPNA patient-block procedure-encounters. After screening, author AJG provided a summary list to the lead author (BAW) for a detailed QI review of these cases to determine the relationship of the EMG reports to the needle location of the block performed and the symptoms for which the postoperative EMG was ordered to specifically evaluate. The presence of preoperative or postoperative spine problems was evaluated by the lead author to determine the relationship of spine pathology level to previous or future QI issues (e.g., cervical spine abnormality that was diagnosed before versus brachial plexus-based patient complaint after having undergone a brachial plexus block). For patients in whom EMG was not ordered, the lead author reviewed the electronic medical record details involving preoperative symptoms, timing of onset of postoperative symptoms, operative notes, coinciding spine pathology, and timing of symptom resolution, if applicable. For cases 801 through 1830, the lead author was responsible for both screening and conducting a detailed review of all records. In other words, all 1830 patient-block encounter medical records were reviewed not only for the presence of any EMG testing, but also for the presence of potential PNI symptoms without evidence of EMG testing.
The following block types were recorded during QI datasheet collation: (i) brachial plexus below the clavicle (typically axillary), (ii) brachial plexus above the clavicle (typically interscalene or supraclavicular), (iii) L2-L4 only (i.e., psoas compartment, femoral, or saphenous), (iv) L2-L4 and L4-S3 in which the L2-L4 block was specifically at the level of the psoas compartment, (v) L2-L4 and L4-S3 in which the L2-L4 was specifically of the femoral nerve in the groin, and (vi) popliteal sciatic with or without a separate saphenous nerve block (i.e., specifically for foot-ankle surgery). The timing of EMG testing was recorded as follows: (i) no pre-or postoperative EMG testing of the relevant nerve distribution, (ii) only preoperative EMG testing without postoperative EMG testing, (iii) postoperative EMG testing without any preoperative EMG testing, and (iv) both preoperative and postoperative EMG testing. For any postoperative EMG testing, we specified in our collated dataset if the electronic medical record indicated that the ordering provider (e.g., surgical team) mentioned in the medical record a specific concern about the nerve block as the reason for the EMG referral (i.e., no-yes dichotomous variable). Dichotomous variables were assigned accordingly if an identified EMG lesion correlated with the needle location for the block used. Patients were not contacted as part of this QI review. However, if the surgical team deemed it appropriate, they notified the anesthesia service on a discretionary basis of any possible complications of which they felt the anesthesia service needed to be aware, and such notification may have involved the anesthesia care team member contacting the patient as part of the care process and follow-up.
Coinciding 30-day mortality data from the Veterans Affairs Surgical Quality Improvement Project (VASQIP [7] ), 2006-2014. The VA National Surgery Office (NSO) publishes a quarterly report to provide the Veterans Integrated Service Network (VISN) Surgical Work Group and Facility Surgical Work Groups, as defined in Veterans Health Administration (VHA) Handbook 1102.01, with a standardized set of surgically relevant information upon which to evaluate local and VISN surgical delivery systems, best practices, and the overall quality of surgery services. The NSO Quarterly Report is designed to facilitate a community of surgical practice and the delivery of high-quality and timely surgical services to our nation's veterans. For this manuscript, we will present only 30-day VASQIP morbidity and mortality data originating from the Orthopedics category at VAPHS. Of note, for VASQIP NSO quarterly reports, orthopedic mortality may have included orthopedic spine or other cases for which regional anesthesia was not an available care option. In addition, VASQIP NSO quarterly reports involve the comparison of a single VA hospital (e.g., VAPHS, and an "observed 30-day mortality") against aggregate VA nationwide data ("expected 30-day mortality") in creating "observed-to-expected" 30-day morbidity and mortality ratios. One limitation of VASQIP mortality data is that all 30-day mortalities are captured in the numerator, but not all survivals are captured in the denominator (as VASQIP represents a minimum sampling per institution that is to include all morbidities/ mortalities in the numerator). Therefore, we will present quarterly trend data for VAPHS orthopedics before and after the start of our MMPNA nerve-block service. We will perform associated (i.e., association, not causation) statistical analyses of before and after aggregate data (30-day O-E mortality ratios) with the understanding that the mortality ratios for both "observed" and "expected" do not include the full denominator of surgical survivors.
We also tracked elective joint replacement mortalities throughout the 2006-2014 period (with complete denominators), and compared before and after the Acute Pain Medicine/Regional Anesthesia specialty service was inaugurated in July 2011.
Statistical Analyses
As a retrospective review of a QI database not originally intended for scientific/extramural reporting, there were no detailed analysis plans a priori. Descriptive statistics (proportions, 95% confidence intervals) are provided, and associated conclusions are presented as simply a comparison of our 95% confidence intervals against complication rates reported in the literature.
Complication Benchmarks in Multimodal Perineural Analgesia
For the O-E 30-day morbidity/mortality ratios, raw ratios between zero and one were translated as "lower than national VA trend," while raw ratios greater than one were translated as "higher than national VA trend." However, as these raw ratios varied from greater than one to less than one, we were required to transform the raw ratio data to establish a "true zero." To do so, each raw ratio data point was squared (i.e., raised to the second power) for proportional comparisons of the O-E ratio.
1 Mortality data were then compared before versus after the Acute Pain Medicine/Regional Anesthesia Service was established (2006 through June 2011, then July 2011 through December 2014) using the student's t-test.
For the "before-after" absolute mortality calculations after elective joint replacement surgery (knee and hip, with known case denominators), associated differences in this outcome were evaluated using the Fisher's Exact Test. These O-E data and before-after joint replacement mortality data were analyzed with IBM SPSS v21 statistical software (IBM SPSS V R , Chicago, IL).
Results
Total encounters, and categorizing blocks for surgery versus blocks for analgesia. From July 1, 2011 until December 31, 2014, there were a total of 1830 patient-block encounters involving the Acute Pain Medicine/Regional Anesthesia Service utilizing MMPNA. Of note, 51% (n ¼ 937) of these blocks were used for "surgical anesthesia" (involving a higher concentration of local anesthetic to provide operating conditions not requiring other general or regional anesthesia). The remainder were typically designed for "postoperative analgesia," meaning that the block was also combined with a spinal anesthetic (n ¼ 685; 77%) or a general anesthetic (i.e., with a secured airway, n ¼ 210; 23%) to achieve necessary surgical conditions. Most (n ¼ 1748; 96%) blocks were placed before surgery, and most patients (n ¼ 1339; 73%) were nondiabetic at the time of the block.
Types and timing of blocks performed, and postoperative frequency of EMG testing. The types of blocks performed are categorized in Table 1 .
Of the EMG reports available on the computerized medical records for the patients associated with these n ¼ 1830 patient-block encounters, (i) n ¼ 242 EMGs were performed only before the surgery/block, (ii) n ¼ 58 EMGs (n ¼ 34 lower extremity and n ¼ 24 upper extremity) were performed only after the day-of-surgery/block, and (iii) n ¼ 15 had EMGs both before and after the surgery/block (n ¼ 14 of these were upper extremity surgery-blocks, and one was foot-ankle). The EMG studies performed only before the surgery/block (n ¼ 242) were excluded from subsequent analysis, and n ¼ 73 EMGs were included for analysis. Four of these 73 EMGs were repeat postoperative EMGs, so there were 69 total patients with any postoperative EMG.
There were n ¼ 38 upper extremity patient EMGs, and n ¼ 35 lower extremity patient EMGs (73 EMGs total across 1830 patient-block encounters, or 4%). Of the 73 total patient-block encounter EMGs, n ¼ 54 were nondiabetic and n ¼ 19 were diabetic.
Electronic medical records were reviewed for the 69 patients who underwent the total of 73 postoperative EMG evaluations. Before the EMGs were performed, 13 of the patient-specific EMG order/consultations indicated concerns specifically relevant to the nerve block performed. The other 56 patients' EMGs were ordered for reasons in which no concern regarding the nerve block was specified; 55 of these 56 patients' EMG reports did not indicate any findings suggestive of a lesion traceable to the nerve block injection, but one of these reports was unable to rule out a possible specific PNI case (not necessarily traceable to the block site) distinguished from long-standing preoperative pathology attributable to the lumbar spine (and previous spine surgery). Therefore, of 13 EMGs specifically ordered to address nerve block concerns, 2 were "definite" PNI cases (2/1830, or 0.11%), and 4 were "possible" PNI cases. Adding the 1 "possible" PNI case from the 56 EMGs ordered (unrelated to block concerns) leads to 2 "definite" and 5 "possible" (from the 13 EMGs concerned with the nerve block) and yields an incidence of 7/1830 (0.38%) "definite or possible" PNI.
EMG Case Details
Popliteal (with or without saphenous, n ¼ 328). Of the seven numerator patients with definite or possible lesions on EMG, one had a popliteal-saphenous block for surgical anesthesia and a definite PNI lesion ("definite POP," 1/328, 0.3%, 95% CI: 0.05%, 1.7%) and one had a possible PNI popliteal-saphenous analgesic block combined with a spinal ("possible POP-SPI" case, with cumulative popliteal risk being 2/328, 0.6%, 95% CI: 0.17%, 2.20%). The definite POP case (who was not diabetic and had no previous symptomatic complaints) on the postoperative EMG was found to have profound bilateral peripheral lower extremity neuropathy, and a presumably new lesion traceable to the block needle in the popliteal fossa. It is conceivable that this case may have instead involved postoperative bilateral inflammatory neuropathy after one-sided surgery with regional anesthesia, as has been reported recently [8] . Meanwhile, the possible POP-SPI case had diffuse bilateral EMG findings, and a common peroneal EMG focus "of questionable significance." The lumbar spine MRI of the possible POP-SPI case also showed some anatomic lesions unrelated to the block. The consulting neurologist ultimately ascribed a diagnosis of "intermittent sciatica" for the possible POP-SPI case.
Interscalene (n ¼ 278). One of the seven "definite or possible" patients had an interscalene block for surgical anesthesia ("possible ISB case," 1/278, 0.4%, 95% CI: 0.06%, 2%). The ISB case manifested as a winged scapula postoperatively that was undocumented preoperatively. The occupational mechanism of injury leading to the need for the surgical procedure was an abrupt "heavy tugging" of a free-falling 300-lb (136-kg) weight on a pulley, resulting in a distal biceps rupture and a possibly undetected simultaneous isolated long thoracic nerve injury. We attribute the EMG finding to the mechanism of injury and not to the block, but still conservatively categorize the case as "possible."
Lumbar plexus psoas compartment block with either parasacral or gluteal sciatic block (n ¼ 494). Four of the remaining seven "definite or possible" patients had lumbar plexus blocks with either parasacral or gluteal sciatic L4-S3 blocks. Two of these four patients had spinal anesthesia with preoperative psoas compartment and parasacral blocks for hip surgery. One lesion was traceable to the lumbar plexus ("definite HIP-LUM"). The other lesion was traceable to the proximal sciatic nerve at the level of the long head of the biceps ("possible HIP-PS," of questionable proximity of the parasacral injection site; the primary causative factor was indeterminate, but favoring surgical stretch over the injection site, perhaps in a "double crush" phenomenon). The third of four patients ("possible LUM-SCI knee") had surgical lumbar plexus and gluteal sciatic anesthetic blocks for knee replacement. The fourth of four patients ("possible LUM-SCI ankle") had lumbar plexus and sciatic blocks for many ankle procedures. Therefore, the risk proportion calculation, given that this category includes two anatomically separate blocks, is: one "definite" case/494 patients, 0.2%, 95% CI: 0.07%, 0.6%; versus four "definite or possible"/494 patients, 0.8%, 95% CI: 0.28%, 2.4%). So in these 494 patients, 988 total blocks (excluding spinals) were performed; our 95% confidence intervals conservatively reflect "patients" (n ¼ 494), not "blocks" (n ¼ 988).
The definite HIP-LUM case had two normal EMGs at our hospital facility, reflecting a normal L2-L4 peripheral sensory exam, but two "second opinion" EMGs at outside hospitals performed paraspinous EMG/myography showing a profound lesion within the lumbar plexus itself that our hospital's EMGs did not specifically test for.
The possible HIP-PS case first manifested symptoms 2 weeks postoperatively. The lesion was localized in the proximal sciatic nerve distribution, in that the long head of the biceps was affected during myography (failing to rule out surgical stretch), but the gluteal musculature was unaffected (less favoring a parasacral plexus needle lesion). Therefore, the EMG was partially able to favor surgical stretch and partially rule out the focal needle injection site. This possible HIP-PS patient was reported to be a noncompliant diabetic, which may have complicated matters postoperatively (including the absence of symptoms until 2 weeks postoperatively), all of which factor against the PNI focus being the parasacral block injection site. The possible LUM-SCI knee PNI case (total knee replacement) had a known problematic lumbar spine, diabetes with peripheral polyneuropathy, and had recorded in the medical records a statement that he also encountered many of his postoperative symptoms preoperatively. There was no EMG myography testing for gluteal/hamstring evaluation for a complete evaluation of the sciatic nerve on the possible LUM-SCI knee patient, because this patient underwent EMG testing while therapeutically anticoagulated with warfarin.
The possible LUM-SCI ankle case was a diabetic who had previously undergone three major lumbar spine surgeries in our institution and seven foot/ankle procedures. In two separate postoperative EMG reports (in 2013 and 2014), the interpretation was unable to exclude a superimposed ipsilateral L5-S1 focal versus neuraxial radiculopathy, given a longstanding sensory-motor peripheral polyneuropathy with chronic axonal loss.
Conservative approach to expand the risk probability and its 95% confidence interval. In a separate chart review of patients not referred for EMG, there were seven cases of abnormal postoperative physical exam findings that were judged (by authors BAW and JWI) to be possibly block related, for which there was no EMG ordered to appropriately evaluate. Based on the proportions described above, we will assume that if these seven had had EMGs ordered, three may have proven to be positive. Therefore, in our conservative estimation, the risk of PNI from MMPNA injections that has been (or may be) traceable to the site of nerve block injection is 10/1830, or 0.55%. The 95% confidence interval of this incidence is 0.27% to 1.08%.
Coinciding 30-day orthopedic morbidity/mortality data from the Veterans Affairs Surgical Quality Improvement Project (VASQIP [7] ), 2006-2014 (Figure 1) . In January 2011, our institution implemented a new "preoperative optimization" program ("Interdisciplinary Medical Perioperative Assessment Consultation Treatment," abbreviated as IMPACT) that can be summarized as reasonably equivalent to the advances described in the literature addressing perioperative surgical homes [9] . In July 2011, the regional anesthesia team was created, but was not fully operational on a daily basis until February 2012. Before the creation of the IMPACT program and regional anesthesia team, the overall O-E ratios for morbidity and mortality were 1.18 (1.04, 1.33) and 1.24 (0.93-1.59), respectively. After the regional anesthesia team was created and through December 2014, the O-E ratios were 0.72 (0.50, 0.97) and 0.22 (0.00, 0.74; P ¼ 0.001 for both morbidity and mortality, respectively, based on the t-test). These values represent (based on transformed ratio statistics to a common zero) reductions in observed-to-expected morbidity and mortality ratios of 22% and 58%, respectively. We were statistically unable to delineate morbidity/mortality reductions traceable specifically to the perioperative surgical home equivalent versus the effect of near-ubiquitous regional anesthesia and reduction in GETA use. Unfortunately, we were also unable to track proportions of complicated patients that were elective orthopedic procedures (e.g., TKA, THA, with full surgical-home equivalent workup 2011-2014) versus emergency procedures (e.g., hip/femur fracture repair with no elective workup and health status optimization). Therefore, we are unable to speculate about the trade-off of PNI complications with the advent of the new block team (we do not have PNI data from 2006-2012 during the GETA-only era) in exchange for reduced 30-day mortality (as we are unable to delineate reduced mortality as being from GETA avoidance versus better preoperative selection and optimization), but we include our "before-after" mortality data in an effort to allow other research teams to generate hypotheses and calculate sample sizes.
Coinciding 30-day orthopedic mortality data after THA and TKA from institutional data, 2006-2014 (Table 2) . 
Discussion
The complexities of forecasting the risk of PNI, irrespective of neurolocation technique, have recently been published (2015) in the Second Practice Advisory of the American Society of Regional Anesthesia and Pain Medicine [10] . For common PNB techniques entailing the use of plain local anesthetics, the rates of PNI after interscalene brachial plexus block, axillary brachial plexus block, and femoral nerve block have been reported as 2.84% (95% CI: 1.33-5.98%), 1.48% (95% CI: 0.52-4.11%), and 0.34% (95% CI: 0.04-2.81%), respectively, based on detailed review of prospective randomized studies to date as of 2007 reported by Brull et al. (n ¼ 10,309) [11] . In a single-institution study (Fredrickson and Kilfoyle [12] ) of 1010 consecutive peripheral nerve blocks with plain local anesthetics, new, all-cause, neurological symptoms were present in 56/690 blocks (8.2%; 95% CI: 6.8-10.2%) at day 10, 37/1010 (3.7%; 95% CI: 2.7-5.0%) at 1 month, and 6/1010 (0.6%; 95% CI: 0.27-1.3%) at 6 months [12] . Most symptoms in this [12] study were due to causes unrelated to the block: 4 of 1010 were ultimately unrelated to the block, but for the other 2/1010 (0.2%), attribution to the block could not be ruled out. In another study, the Australasian Collaboration (Barrington et al. [13] ) cites a PNI incidence of 0.04% and a 95% confidence interval of 0.08 to 1.1 per 1000 (0.008-0.11%); this study counted each block in the denominator (7156 blocks among 6069 patients). Watts and Sharma [14] reported a 0.22% PNI incidence (n ¼ 1065 consecutive blocks over a 12-month period), while Laur et al. [15] reported a 0.32% short-term PNI incidence (n ¼ 4363, 14 cases over a 15-month period).
We took a deliberate and conservative approach by (i) categorizing positive EMGs with questionable involvement of the needle location as potentially attributable to the block (in isolation or as part of a "double-crush" phenomenon) and (ii) adding three cases to the numerator (i.e., patients who did not have EMGs). These conservative tabulations led to our 0.55% risk estimate with a 95% confidence interval of 0.27% to 1.08%. We are confident based on this detailed review of 1830 patientblock encounters that there were not any missed complications, with the exception of patient relocation or death (< 1%). However, of the seven EMG-specific cases in the numerator, the following five cases are questionable at best for block-related PNI: POP-SPI, ISB, HIP-PS, LUM-SCI knee, and LUM-SCI ankle. Subtracting these five cases from the numerator, along with subtracting the theoretical three additional numerator cases that did not have EMG, yields a risk incidence of 2/1830 (0.11%), with a 95% CI of 0.03%-0.4%.
A frequent complex case under the auspices of our teaching institution's Acute Pain Medicine/Regional Anesthesia service is elective total hip arthroplasty (THA, n ¼ 237 in our data set). In literature review, the risk of Figure 1 Reductions in institutional orthopedics morbidity and mortality observed-to-expected ratios The X-axis represents the timeline of 2006-2014 orthopedics cases performed at the VA Pittsburgh Health System. The Y-axis O:E ratio represents the observed-to-expected ratio of morbidity (dotted black line) and mortality (dashed gray line) for tracked cases in quarterly VASQIP reports from the VA Central National Surgery Office (see text for details). The "observed" value represents actual complications observed during a quarterly audit (at VA Pittsburgh), which is compared with "expected" complications based on the same summed quarterly audit of all VA hospitals nationwide. The ratio value of 1 indicates that the VA Pittsburgh morbidity/mortality rates match those of national trends for the same time period. Less than 1 indicates the VA Pittsburgh having better outcomes than those of national trends (a ratio of 0.5 indicates half the complication rate of national). Greater than 1 indicates the VA Pittsburgh having less satisfactory outcomes than those in national trends (a ratio of 2.0 indicates twice the complication rate of national). The timeline arrows at the top of the graph reflect the inauguration of the perioperative surgical home in January 2011, the start of the block team in July 2011, and the fully-staffed daily block team in February 2012. Note that all complications recorded are irrespective of hospital inpatient status (i.e., not routed through the perioperative surgical home equivalent, such as hip fracture patients) versus outpatient status (outpatients routed through the surgical home equivalent, such as for knee or hip replacement). Quarterly data are annualized for ease of interpretation. Based on the t-test, the before versus after P value of the O:E ratios were P ¼ 0.001 for both morbidity and mortality (see text for details). No further statistical delineation of the effects of the surgical home versus block team was possible.
PNI (from all causes, not just those related to nerve blocks) from hip replacement ranges from 0.2% to 8% [16] . We had one lumbar plexus PNI case traceable to the injection site (definite HIP-LUM patient above), and one L4-S3 PNI case that did not involve the gluteal musculature on EMG, but did involve the long head of the biceps (possible HIP-PS patient above with uncontrolled diabetes). There was one other patient with postoperative symptoms (but no EMG) that were deemed to be possibly block related. There were also 19 THA patients with negative EMGs (n ¼ 4), and no EMGs but L2-S3 symptoms (n ¼ 15) not traceable to the block (based on surgical notes and/or procedural descriptions). So the overall THA PNI risk in our teaching institution was 9% (22/237, approximating the 8% range reported by Zappe et al. [16] ). We consider our findings to be in a generally accepted risk range for rare complications after THA with proximal peripheral nerve blocks (n ¼ 1-3 out of 237, 0.4-1.3%, for dual blocks of the lumbar and parasacral plexi).
Lumbar plexus blocks (in combination with parasacral blocks for hip surgery or in combination with gluteal sciatic blocks for lower extremity surgery distal to the hip) have the least available data regarding risk epidemiology. To our knowledge, the largest series reported to date entails 394 blocks performed in France during a voluntary hotline data collection report in a 10-month period from 1998-1999 (n ¼ 158,000 blocks; lumbar plexus block-related major complication rate of 0.8% [17] ). Our series of lumbar plexus blocks for surgical anesthesia and/or postoperative analgesia to date has since well surpassed n ¼ 500 (July 2011-December 2014, n ¼ 494). In our case series of n ¼ 494 patients (through December 2014) having undergone lumbar plexus block, we reiterate from above that 13 patients had EMGs ordered that were specifically addressing postoperative concerns of the perioperative nerve block. Of these 13 patients, 7 had lumbar plexus blocks, with 4 being for hip replacement and 3 for knee replacement. In total, only one of the seven EMGs had plexus injury traced to the lumbar plexus needle injection site.
This was for hip surgery using an analgesic block with BPV-CBD.
During the July 2011-December 2014 time period, in addition to the 13 EMGs above that were ordered citing concerns with the perioperative nerve blocks, there were 56 other patients with EMGs ordered without specific mention of nerve block concerns. Of these 56, 5 patients had lumbar plexus blocks and none of these EMGs showed evidence of damage in proximity to the lumbar plexus site of injection (with one of these cases, LUM-SCI ankle, having a possible "unable to rule out" status). Therefore, 1/494 (0.2%; 95% CI: 0.04%-1.14%) of our patients having lumbar plexus blocks had definite PNI evidence per EMG at the site of injection.
Our overall objective of presenting these benchmark QI outcome data is to narrow down the scope of future research hypotheses involving MMPNA. Based on our institution's limited sample size in the context of the world's literature, we do not detect trends of PNI specifically traceable to the use of MMPNA in our institution when compared with all blocks performed worldwide using plain local anesthetics. As a QI-driven clinical activity, there are restrictions in data gathering and synthesis that forbid identifying preoperative/postoperative opioid requirements (e.g., related to possible PNI symptom management) and other factors related to general health status (i.e., "trade-off" of one set of possible complications [from peripheral nerve block]) for another [from GETA]). None of our observations should be interpreted as suggestive for future (and acknowledged offlabel) clinical practice. Due diligence in preclinical research has been done with respect to known neuronal safety (in vitro [1] , CBD adjuvants) and more recently with respect to drug compatibility and in vivo safety in laboratory animals [2] . Previously published [3, 4] in this journal is our report of associated block durations and rebound pain scores observed after these MMPNA blocks, but (as a clinical pathway) these outcomes were not compared with a plain local anesthetic control group. We reiterate that in the absence of an industry sponsor, such research (or hypothesis generation for such research) would either occur slowly or not at all. Perhaps future research across several coordinated centers may help better delineate risk incidence (while narrowing the 95% confidence interval by increasing the sample size), although funding for such research (i.e., involving drugs that are no longer patent-protected, and not involving delineation of perineural mechanism of action) may not necessarily come from conventional sources beyond interinstitutional cooperation.
Conclusions
In this single-institution QI data review involving 1830 patient-block encounters entailing over 2600 blocks with multimodal perineural analgesia for either surgical anesthesia or postoperative analgesia, our patient-specific incidence of definite PNI was 0.11% (2/1830). When including possible PNI cases with EMG testing (n ¼ 5) and possible PNI cases that did not have EMG testing (n ¼ 3), our conservative estimate for PNI risk is 0.55% (10/1830).
